Pages that link to "Q35124106"

The following pages link to Prognostic role of NLR in urinary cancers: a meta-analysis (Q35124106):

Displaying 43 items.

• Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis (Q26765926) (← links)
• Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis (Q26769591) (← links)
• Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis (Q28083684) (← links)
• Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis (Q28552296) (← links)
• Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model (Q33563230) (← links)
• Neutrophil to Lymphocyte Ratio (NLR) at the Time of Transurethral Resection of Bladder Tumor: A Large Retrospective Study and Analysis of Racial Differences (Q33614530) (← links)
• Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma (Q35594253) (← links)
• Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients (Q35817001) (← links)
• Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer (Q36069609) (← links)
• Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy. (Q36195647) (← links)
• The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer (Q36264797) (← links)
• Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy (Q36654421) (← links)
• Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer (Q37170563) (← links)
• Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study (Q37221777) (← links)
• Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients (Q38623275) (← links)
• Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy. (Q38833996) (← links)
• Predictive value of preoperative neutrophil-to-lymphocyte ratio on the prognosis of germ cell testicular tumors (Q38922125) (← links)
• Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy (Q39093002) (← links)
• Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710. (Q39243899) (← links)
• Predictive role of hematologic parameters in testicular torsion (Q39467452) (← links)
• The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease (Q39679251) (← links)
• Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis (Q39739037) (← links)
• Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma (Q40069125) (← links)
• Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer. (Q40824744) (← links)
• Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer. (Q41116973) (← links)
• The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis (Q41545194) (← links)
• Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer (Q42152624) (← links)
• Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer (Q42378488) (← links)
• The authors reply: Predictive role of hematologic parameters in testicular torsion (Q42482055) (← links)
• INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. (Q43688428) (← links)
• Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma. (Q45934145) (← links)
• Can haematologic parameters be used for differential diagnosis of testicular torsion and epididymitis? (Q48154176) (← links)
• Pre-treatment neutrophil-to-lymphocyte ratio predicts survival in patients with laryngeal cancer (Q49334897) (← links)
• The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer (Q50581538) (← links)
• Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer (Q51064514) (← links)
• Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer (Q51487533) (← links)
• Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. (Q53484321) (← links)
• Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer. (Q53981393) (← links)
• The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study. (Q54964281) (← links)
• Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression? (Q57056280) (← links)
• Advances in pancreatic cancer biomarkers (Q64233995) (← links)
• Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis (Q88674554) (← links)
• Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer (Q92141686) (← links)